(MENAFN- America News Hour) The HEMODYNAMIC MONITORING MARKET is thriving on account of the rising awareness amongst individuals for the benefits of maintaining a good health and the increasing need for high quality healthcare services amongst individuals. With the increasing prevalence of diseases worldwide, people are opting for products that help them to stay fit and are also investing more on healthcare services. Alternatively, Pharmaceutical manufacturers, along with other healthcare companies that manufactures devices and equipment, are increasingly focusing on the research and development of advanced treatment, drugs and equipment for the diagnosis and treatment of the diseases and for developing healthcare products. Organizations are raising their R & D expenses year-on-year so as to deliver quality healthcare products in the years to come. The advancements in the healthcare sector are also supported by the governments of nations worldwide with numerous financial aids. According to a statistical report titled ' Global Spending on Health: A World in Transition ', released in theyear 2019 by the World Health Organization (WHO), the global spending on healthcare recorded USD 7.8 trillion in 2017, which was an increase by USD 0.2 trillion from the recorded value of USD 7.6 trillion in 2016.
Download Sample of This Strategic Report:
Nuclear imaging is an incipient imaging innovation that uses a little amount of radioactive substance connected to compounds utilized by the body's cells or exacerbates that append to tumor cells. Utilizing hi-tech detection devices, the radioactive substances can be situated in the body to see when and where they concentrate, and this procedure has the capacity of improving disease prevention, clinical research, and medical treatment. The emergence of healthcare devices has fulfilled the growing needs for enhanced diagnostics. These technologically advanced systems have overtaken the conventional systems based on precision and accuracy of images.
End-user/Technology
The top users of this technology are mostly from Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies), diagnostic centers & research institutes.
Market Dynamics
Global Hemodynamic Monitoring Market is expected to grow at a CAGR of 6% for the next decade . Major determinants for the development of the market are increasing usage of SPECT, and PET analysis, rising awareness of individuals for radiopharmaceuticals, and easy accessibility of radiopharmaceuticals .Novel applications, for example, Alzheimers and continually growing oncology application segment also drive the market.
Market Segmentation
On the basis of technology, the nuclear imaging market can be segmented as PET (oncology, cardiology, neurology, and others), PET/CT, SPECT (cardiology, lymphoma, thyroid, neurology, and others), and SPECT/CT. By geography, the market is segmented into North America, Europe, and Asia-Pacific, etc. North America represents the highest share of the worldwide atomic pharmaceutical analytic market; trailed by Europe and Asia-Pacific. Asian nations are believed to demonstrate a developing pattern in this area as a result of increasing diagnostic procedure and ascend in the medical gadget industry.
Regional/Geographic Analysis
Geographically, the global nuclear imaging market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America has the highest share of the PET and SPECT market globally closely followed by Europe. Asia Pacific market is expected to grow at a rapid pace due to rise in aging population, increase in chronic disease prevalence, public and private investments to continuously improve medical infrastructure in the region.
Opportunities
An increment in the frequency of chronic sicknesses, for example, cardiovascular clutters, tumor, and neurological issue, technological headways, and ascend in mindfulness about the early conclusion have fuelled the development of the medical imaging systems market. In addition, an increment in maturing populace, development sought after for imaging system procedures, and growth in consumption of human services is anticipated to additionally fuel the market development. Notwithstanding, costly imaging systems combined with unfavorable government activities have ruined the development of the market in the developing countries. Furthermore, technological progress in instruments and expanding interest for non-invasive diagnostic imaging techniques add to the development of the worldwide nuclear imaging market.
Download Sample of This Strategic Report:
Key Players
Some of the key players in the market are GE Healthcare, SiemensHealthcare, Koninklijke, Philips, Digirad, Mediso Medical Imaging Systems, DDD-Diagnostics A/S, Siemens Healthcare, Neusoft Medical Systems Co. Ltd., Toshiba Medical Systems Corporation, SurgicEye GmbH, Mediso Medical Imaging Systems, Ltd., and CMR Naviscan Corporation, Agfa-Gevaert N.V, Cardiarc Ltd, Covidien Plc, Digirad Corporation, Gamma Medica Inc, Medx Inc, Naviscan Inc, Positron Corporation, Royal Philips Electronics, Segami Corporation, Siemens Healthcare, and Spectrum Dynamics Ltd.
Some of the key players in the market are GE Healthcare, SiemensHealthcare, Koninklijke, Philips, Digirad, Mediso Medical Imaging Systems, DDD-Diagnostics A/S, Siemens Healthcare, Neusoft Medical Systems Co. Ltd., Toshiba Medical Systems Corporation, SurgicEye GmbH, Mediso Medical Imaging Systems, Ltd., and CMR Naviscan Corporation, Agfa-Gevaert N.V, Cardiarc Ltd, Covidien Plc, Digirad Corporation, Gamma Medica Inc, Medx Inc, Naviscan Inc, Positron Corporation, Royal Philips Electronics, Segami Corporation, Siemens Healthcare, and Spectrum Dynamics Ltd.
Report ContentsRegional AnalysisReport Highlights
Market segments
Market Drivers, Restraints and Opportunities
Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Market – Current Trends
Competition & Major Companies
Technology and R & D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players
North America
US and Canada
Latin America
Mexico, Brazil, Argentina and Rest of Latin America
Western Europe
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe
Download Sample of This Strategic Report:
Eastern Europe
Russia
Poland
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia and New Zealand
Rest of Asia Pacific
Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
South Africa
North Africa
Rest of Middle East and Africa
About Us
Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation.
Contact Us
Kenneth Research
Email:
Phone:+1 313 462 0609
Leonard Thomas
Leonard Thomas is an energetic and versatile freelance writer for 5 years, he pen down any type of articles and web content. he is a Cambridge University Business English Certificate (Europe Level) holder . he is analytical, enthusiastic and ingenious, with the essence to work variously, strives to emerge as a lucrative individual who has a grasp on market. Congenial Interpersonal skills and the competence to grab every single trivia with foolproof analysis is something he primarily posses .
MENAFN18022021004545010068ID1101621736